Evidence map›Paper›PMID 22441255›Full record

ArticleAIDS (London, England)2012

Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa.

Aaron A R Tobian, Godfrey Kigozi, Patti E Gravitt, Changchang Xiao, David Serwadda, Kevin P Eaton, Xiangrong Kong, Maria J Wawer, Fred Nalugoda, Thomas C Quinn and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in AIDS (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  17. Article
  18. Article
  19. Human Papillomavirus: The Equal Opportunity Pathogen.The Journal of infectious diseases · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Aaron A R TobianDepartment of Pathology, School of Medicine, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21287, USA. atobian1@jhmi.edu
Godfrey Kigozi
Patti E Gravitt
Changchang Xiao
David Serwadda
Kevin P Eaton
Xiangrong Kong
Maria J Wawer
Fred Nalugoda
Thomas C Quinn
Ronald H Gray
Johns Hopkins University · USRakai Health Sciences Program · UGMakerere University · UGNational Institute of Allergy and Infectious Diseases · USPerdana University · MY

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000010 · FIC · JOHNS HOPKINS UNIVERSITY · PI BEYRER, CHRISTOPHER C. · 1988 to 2012
$19.8M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; RakaiU01AI075115 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2007 to 2011
$9.3M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Research Infrastructure for the Hopkins Population CenterR24HD042854 · NICHD · JOHNS HOPKINS UNIVERSITY · PI CHERLIN, ANDREW J · 2003 to 2017
$5.1M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
Oncogenic HPV, Mucosal Immune Response and Risk of HIV AcquisitionK23AI093152 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2011 to 2015
$684k
FIC NIH HHS 2D43TW000010-19-AITRPFIC NIH HHS 5D43TW001508FIC NIH HHS D43 TW000010FIC NIH HHS D43 TW001508Intramural NIH HHS ZIA AI000361NIAID NIH HHS 1K23AI093152-01A1NIAID NIH HHS 3U01-AI075115-03S1NIAID NIH HHS K23 AI093152NIAID NIH HHS U01 AI051171NIAID NIH HHS U01 AI068613NIAID NIH HHS U01-AI-068613NIAID NIH HHS U01 AI075115NIAID NIH HHS U1AI51171NICHD NIH HHS R24 HD042854
6 · The paper itself

Abstract

objectivesHigh-risk human papillomavirus (HR-HPV) infection is the most common sexually transmitted infection. Penile and cervical cancer rates are highest in sub-Saharan Africa. However, little is known about the impact of HIV infection on HR-HPV acquisition and clearance among heterosexual men.

designHR-HPV incidence and clearance were evaluated in 999 men (776 HIV-negative and 223 HIV-positive) aged 15-49 years who participated in male circumcision trials in Rakai, Uganda.

methodsPenile swabs were tested for HR-HPV by Roche HPV Linear Array. A Poisson multivariable model was used to estimate adjusted incidence rate ratios (adjIRRs) and clearance risk ratios (adjRRs).

resultsHR-HPV incidence was 66.5/100 person-years in HIV-positive men and 32.9/100 person-years among HIV-negative men [IRR=2.02, 95% confidence interval (CI) 1.67-2.44]. Incidence was higher in the unmarried men (adjIRR=1.73, 95% CI 1.19-2.52), and decreased with age (adjIRR for men >35 years=0.64, 95% CI 0.43-0.94) and male circumcision (adjIRR=0.70, 95% CI 0.55-0.89). HR-HPV clearance was 114.7/100 person-years for HIV-positive men and 170.2/100 person-years for HIV-negative men (risk ratio=0.67, 95% CI 0.59-0.77). HR-HPV clearance in HIV-negative men increased with circumcision (adjRR=1.48, 95% CI 1.26-1.74), HSV-2 infection (adjRR=1.20, 95% CI 1.01-1.44), and symptoms of urethral discharge (adjRR=1.35, 95% CI 1.06-1.73). Clearance of HR-HPV was significantly lower for unmarried men (adjRR 0.76, 95% CI 0.59-0.98).

conclusionHR-HPV is common among heterosexual Ugandan men, particularly the HIV-infected. HIV infection increases HR-HPV acquisition and reduces HR-HPV clearance. Promotion of male circumcision and additional prevention measures, such as HPV vaccination, is critical in sub-Saharan Africa.

Indexed as

AdolescentAdultCircumcision, MaleHerpesvirus 2, HumanHeterosexualityHIV InfectionsHumansIncidenceMaleMarital StatusMiddle AgedPapillomaviridaePapillomavirus InfectionsPenisRisk FactorsSexual Behavior

Identifiers

PMID22441255
PMCPMC3442933
OpenAlexW2029460646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.